IRVINE, Calif., May 17, 2005 (PRIMEZONE) -- Due to an editorial error, SmallCap Sentinel incorrectly stated in the May 13, 2005, press release for Xenomics Inc. that Xenomics had associations with medical testing laboratories LabCorp, Quest Diagnostics Inc., and Specialty Laboratories, Inc.
SmallCap Sentinel analyst D.R. Clark commented on May 13, 2005 on the May 9 and May 12, 2005, news items from Xenomics, Inc. (OTCBB:XNOM), in which the company announced that it had signed research contracts to begin human clinical trials of the Company's proprietary diagnostic DNA technology for the creation of completely safe and non-invasive prenatal tests for a range of genetic abnormalities, such as Down syndrome.
Forward-Looking Statements
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience. The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. Xenomics, Inc. has agreed to pay MP fifteen hundred dollars for preparation and distribution of this report. Additionally, MP and/or its affiliates, associates and employees from time to time may have either a long or short position in any securities mentioned. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.